Name: Spanish biotech spin-offs and their integration into the global ecosystem: reaching out and attracting EU, US and Asia players.
Start: 2026-09-29T14:30:00+0200
End: 2026-09-29T15:15:00+0200

Spanish biotech spin-offs and their integration into the global ecosystem: reaching out and attracting EU, US and Asia players.

Tuesday September 29, 2026 14:30 - 15:15 CEST

4 Raúl Martín room

Spanish biotech spin-offs are stepping onto the global stage like nimble launchpads of innovation, pulling in investors and partners from Europe, the US and Asia. Rooted in world-class science yet built for translation, they marry academic brilliance with entrepreneurial grit — and with sharper international branding, smoother regulatory pathways and bolder cross-border alliances, they can turn local discoveries into scalable, globe-spanning solutions.

Speakers

Emilio Erazo Fischer

Operating Partne, Asabys Partners

Operating partner at Asabys, Emilio joined the team in December 2024. Emilio supports our biopharma portfolio investments in strategy and business development and currently holds the CBO role at ALLOX.Previously, Emilio led external innovation deals at Boehringer Ingelheim, as Director of Global BD&L Oncology, contributing novel pipeline assets and technology platforms. Emilio has fostered pharma-biotech relationships across Europe, the US and Japan, and served as consultant for... Read More →

Tuesday September 29, 2026 14:30 - 15:15 CEST
4 Raúl Martín room

Round table discussion

Audience English language
Subject Call for sessions, Asabys Partners
Track Finance & investment

BIOSPAIN 2026

Emilio Erazo Fischer

Get help with the event

BIOSPAIN 2026

Emilio Erazo Fischer

Sign up or log in to save this to your schedule, view media, leave feedback and see who's attending!

Get help with the event